Official Journal of EAS
The official journal of the Society is Atherosclerosis. It is published monthly and is a widely read, widely cited, international publication with 2022 Impact Factor of 5.3.
Atherosclerosis brings together from all sources papers concerned with research and investigation on atherosclerosis, its complications, and related diseases, including: lipoprotein metabolism, arterial and vascular biology and disease, thrombosis, inflammation, disorders of lipid transport, diabetes and hypertension as related to atherosclerosis, and cardiovascular risk factors. The editors are also interested in clinical papers dealing with case studies of specific or general interest, new or unusual lipid syndromes, and the genetic basis and familial incidence of atherosclerosis and related diseases. High quality reports of controlled clinical trials of drugs or diets will be considered provided the paper deals with the mechanism of action of the drug or diet.
Browse and publish in Atherosclerosis Journal as an EAS member benefit
Access to Atherosclerosis Journal is included in EAS membership fee, so members can see the latest publications in the field for free. And when it comes to publishing your own findings, as an EAS member, you receive a 25% discount on the open-access fee when you publish in Atherosclerosis.
